Riskpilot← Back to searchSign inGet full accessSOLARIS B AS
ASActiveOrg 982575907Bjønnan 15, 6410 MoldeWholesale of pharmaceutical and medical goods · NACE 4646Est. 20001 employees
Revenue 2025
NOK 0
EBITDA margin
—
-1582% vs 2024
Equity ratio
91.6%
Financial strength
Net profit 2025
NOK 489K
-19% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -169K | -1582% |
| Net profit | NOK 489K | -19% |
| Total assets | NOK 1,9M | +20% |
| Equity | NOK 1,7M | +24% |
| Employees | 1 | — |
Legal name
SOLARIS B AS
Org number
982575907
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. november 2000
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene
Company purpose
Salg av medisinske tjenester og varer samt salg og kjøp av aksjer i andre selskap
Address
Bjønnan 15, 6410 Molde
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 67 | 8 | 257 | 113 | 0 |
| Staff expenses | −2 | −1 | −1 | −1 | −34 |
| EBITDA | −93 | −140 | 110 | −10 | −169 |
| Depreciation & amort. | −17 | −17 | −10 | −0 | −0 |
| EBIT | −110 | −157 | 100 | −10 | −169 |
| Net financials | 890 | 210 | 122 | 615 | 658 |
| Profit before tax | 779 | 53 | 222 | 605 | 489 |
| Tax | 188 | −0 | 15 | 2 | −0 |
| Net profit | 591 | 53 | 207 | 603 | 489 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 834 | 1 286 | 1 319 | 1 581 | 1 894 |
| Equity | 1 232 | 1 085 | 992 | 1 395 | 1 734 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 602 | 201 | 327 | 186 | 160 |
| Total debt | 602 | 201 | 327 | 186 | 160 |
EBITDA margin
-16934000.0%
This company
15.8%
Market median
-107177315% vs market
20212025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20212025
Return on equity
28.2%
This company
18.4%
Market median
+53% vs market
20212025
Net profit margin
48893800.0%
This company
8.1%
Market median
+603627060% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PB Deputy Member | Deputy Member | 2000 |
OJ Chief Executive Officer | Chief Executive Officer | 2000 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SOLARIS B AS 
MEDILASER ASBoard members of SOLARIS B AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Piotr Bartlomiej Wysocki | Deputy Member | 0 companies |
| Olga Joanna Wysocka | Chief Executive Officer | 0 companies |